Medical Journals

Microvascular Function, Metabolic Syndrome, and Novel Risk Factor Status in Women with Cardiac Syndrome X.

Authors:
  • Jadhav Sachin T
  • Ferrell William R
  • Petrie John R
  • Scherbakova Olga
  • Greer Ian A
  • Cobbe Stuart M
  • Sattar Naveed

From: The Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. stjadhav@bigfoot.com

The American journal of cardiology

  • Publish Date: Jun 2006
  • ISSN: 0002-9149
  • Volume: 97
  • Issue: 12
  • Pages: 1727-31
  • Medium: Print
  • Language: English
  • Citation (JAMA): Jadhav Sachin T, Ferrell William R, Petrie John R, et al. Microvascular Function, Metabolic Syndrome, and Novel Risk Factor Status in Women with Cardiac Syndrome X.. Am. J. Cardiol. Jun 2006;97:1727-31

Abstract

To characterize microvascular function, candidate risk pathways, and metabolic syndrome prevalence in women with cardiac syndrome X, 52 nondiabetic women with angiographically normal epicardial arteries but >1 mm of planar ST depression during exercise testing (patients) and 24 healthy controls of similar age were recruited. In addition to fasting blood samples and anthropometric measurements, forearm cutaneous microvascular function after iontophoresis of acetylcholine and sodium nitroprusside was assessed by laser Doppler imaging. Despite body mass index correction and a larger proportion on statin therapy, patients had high levels of insulin (p=0.016), triglycerides (p=0.018), intercellular adhesion molecule-1 (p=0.021), von Willebrand factor (p=0.005), and leptin (p=0.005) and lower levels of high-density lipoprotein cholesterol (p=0.042) compared with controls. Consistent with these data, 30% of patients but only 8% of controls fulfilled criteria for the metabolic syndrome as defined by the National Cholesterol Education Program (p=0.015). Endothelium-dependent and -independent microvascular functions were markedly impaired in patients (p<0.001), and the odds ratio for cardiac syndrome X was 7.38 (95% confidence interval 2.2 to 24.7) if the acetylcholine response was <8,710 flux units. In conclusion, women with cardiac syndrome X more commonly have metabolic syndrome and related adiposity, metabolic, and inflammatory derangements. They also have significantly impaired skin microvascular function as assessed by laser Doppler imaging, consistent with generalized vascular dysfunction, a finding with potential diagnostic implications.

Mesh Headings (Keywords): Acetylcholine, Biological Markers, Blood Pressure, Body Mass Index, Case-Control Studies, Cholesterol, HDL, Exercise Test, Female, Humans, Insulin, Intercellular Adhesion Molecule-1, Iontophoresis, Laser-Doppler Flowmetry, Leptin, Metabolic Syndrome X, Microcirculation, Microvascular Angina, Middle Aged, ROC Curve, Risk Factors, Skin, Triglycerides, Vasodilator Agents, von Willebrand Factor


Check for Full Text / PubMed Unique Identifier (PMID): 16765122


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.